AM-Pharma signed an option to acquisition agreement with Pfizer in 2015.

Contact: Tim Knotnerus at t.knotnerus@am-pharma.com

 


amp-partnering.jpg

Latest News

March 9 2018
AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury
Read more.

May 22 2017
AM-Pharma completes patient recruitment of recombinant human Alkaline Phosphatase
Read more.